The ROC analysis for IL-17A showed AUC values of 0.62 and 0.67 for IM/DYS vs. NAG and H (Table 1), respectively, leading the authors to propose IL-17A as a potent biomarker for predicting IM and/or DYS and improving the prevention of GC. The gene discussed is IL17A; the disease is gastric cancer.